Display options
Share it on

Cureus. 2020 Sep 11;12(9):e10373. doi: 10.7759/cureus.10373.

End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan Region.

Cureus

Ashutossh Naaraayan, Abhishek Nimkar, Amrah Hasan, Sushil Pant, Momcilo Durdevic, Henrik Elenius, Corina Nava Suarez, Prasanta Basak, Kameswari Lakshmi, Michael Mandel, Stephen Jesmajian

Affiliations

  1. Internal Medicine, Montefiore New Rochelle Hospital, Albert Einstein College of Medicine, New Rochelle, USA.
  2. Internal Medicine, Montefiore New Rochelle Hospital, New Rochelle, USA.

PMID: 33062496 PMCID: PMC7550023 DOI: 10.7759/cureus.10373

Abstract

Introduction Several comorbid conditions have been identified as risk factors in patients with coronavirus disease 2019 (COVID-19). However, there is a dearth of data describing the impact of COVID-19 infection in patients with end-stage renal disease on hemodialysis (ESRD-HD). Methods This retrospective case series analyzed 362 adult patients consecutively hospitalized with confirmed COVID-19 illness between March 12, 2020, and May 13, 2020, at a teaching hospital in the New York City metropolitan area. The primary outcome was severe pneumonia as defined by the World Health Organization. Secondary outcomes were the (1) the Combined Outcome of Acute respiratory distress syndrome or in-hospital Death (COAD), and (2) need for high levels of oxygen supplementation (HiO

Copyright © 2020, Naaraayan et al.

Keywords: absolute mortality; acute respiratory distress syndrome [ards]; better outcomes; coronavirus disease 2019 (covid-19); covid-19 pneumonia; end stage renal disease (esrd); maintenance hemodialysis; oxygen support; racial disparity

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Ann Intensive Care. 2019 May 14;9(1):56 - PubMed
  2. J Immunol. 2017 May 15;198(10):4046-4053 - PubMed
  3. J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80 - PubMed
  4. ASAIO J. 2004 Nov-Dec;50(6):lii-lvii - PubMed
  5. J Crit Care. 2019 Oct;53:25-31 - PubMed
  6. Int J Obes (Lond). 2020 Aug;44(8):1790-1792 - PubMed
  7. Int J Infect Dis. 2020 May;94:91-95 - PubMed
  8. Lancet. 2020 Mar 28;395(10229):1033-1034 - PubMed
  9. Kidney Int. 2003 Mar;63(3):793-808 - PubMed
  10. J Ren Nutr. 2012 Jan;22(1):149-56 - PubMed
  11. Kidney Blood Press Res. 2015;40(6):614-22 - PubMed
  12. Semin Dial. 2002 Sep-Oct;15(5):329-37 - PubMed
  13. Hypertens Res. 2017 Apr;40(4):351-352 - PubMed
  14. J Crit Care. 2012 Dec;27(6):714-21 - PubMed
  15. JAMA. 2020 Jun 2;323(21):2192-2195 - PubMed
  16. Aging (Albany NY). 2020 Apr 8;12(7):6049-6057 - PubMed
  17. J Clin Epidemiol. 2008 Apr;61(4):344-9 - PubMed
  18. Kidney Int Rep. 2020 Jun 09;5(8):1333-1341 - PubMed
  19. JAMA. 2012 Jun 20;307(23):2526-33 - PubMed
  20. Clin J Am Soc Nephrol. 2013 Apr;8(4):515-7 - PubMed
  21. J Am Soc Nephrol. 2020 Jul;31(7):1409-1415 - PubMed
  22. Kidney Int. 2020 Jul;98(1):27-34 - PubMed
  23. Cell Mol Immunol. 2016 Jan;13(1):3-10 - PubMed
  24. Circ Res. 2020 Jun 5;126(12):1671-1681 - PubMed
  25. BMJ. 2020 May 22;369:m1985 - PubMed

Publication Types